Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Some drugs can cause hair loss or growth, but hair usually returns to normal after stopping the drug.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Collagen and TGF-β2 help maintain hair cell shape and youthfulness.

Some drugs may cause hair loss in women.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Stem cell vesicles reduced eczema symptoms in mice safely.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

DM and AA may share a common cause.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.